Sarepta Therapeutics Inc (SRPT)
130.58
-0.32
(-0.24%)
USD |
NASDAQ |
May 02, 16:00
130.46
-0.12
(-0.09%)
After-Hours: 20:00
Sarepta Therapeutics Accounts Payable (Quarterly): 91.54M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 91.54M |
December 31, 2023 | 164.92M |
September 30, 2023 | 87.95M |
June 30, 2023 | 109.80M |
March 31, 2023 | 106.71M |
December 31, 2022 | 95.88M |
September 30, 2022 | 118.46M |
June 30, 2022 | 56.21M |
March 31, 2022 | 54.01M |
December 31, 2021 | 76.74M |
September 30, 2021 | 44.16M |
June 30, 2021 | 76.68M |
March 31, 2021 | 76.65M |
December 31, 2020 | 111.09M |
September 30, 2020 | 74.53M |
June 30, 2020 | 91.66M |
March 31, 2020 | 26.60M |
December 31, 2019 | 68.09M |
September 30, 2019 | 81.95M |
June 30, 2019 | 44.04M |
March 31, 2019 | 26.50M |
December 31, 2018 | 33.83M |
September 30, 2018 | 20.41M |
June 30, 2018 | 17.38M |
March 31, 2018 | 17.38M |
Date | Value |
---|---|
December 31, 2017 | 8.467M |
September 30, 2017 | 5.317M |
June 30, 2017 | 10.92M |
March 31, 2017 | 27.45M |
December 31, 2016 | 29.69M |
September 30, 2016 | 20.68M |
June 30, 2016 | 17.13M |
March 31, 2016 | 18.67M |
December 31, 2015 | 20.23M |
September 30, 2015 | 7.431M |
June 30, 2015 | 14.10M |
March 31, 2015 | 9.318M |
December 31, 2014 | 12.41M |
September 30, 2014 | 0.967M |
June 30, 2014 | 1.309M |
March 31, 2014 | 7.721M |
December 31, 2013 | 8.08M |
September 30, 2013 | 8.129M |
June 30, 2013 | 6.727M |
March 31, 2013 | 7.073M |
December 31, 2012 | 7.532M |
September 30, 2012 | 4.334M |
June 30, 2012 | 8.813M |
March 31, 2012 | 8.195M |
December 31, 2011 | 9.396M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
26.60M
Minimum
Mar 2020
164.92M
Maximum
Dec 2023
82.88M
Average
79.34M
Median
Accounts Payable (Quarterly) Benchmarks
PTC Therapeutics Inc | 27.46M |
Amgen Inc | 1.59B |
Regenxbio Inc | 22.79M |
Apellis Pharmaceuticals Inc | 37.52M |
Alnylam Pharmaceuticals Inc | 55.52M |